兆新股份(002256.SZ):擬出售參股公司中小微公司的全部股權
格隆匯8月16日丨兆新股份(002256.SZ)公佈,為壓降公司財務性投資佔比,快速回籠資金償還到期債務並優化公司對外投資結構,同時進一步聚焦主營業務、改善資產結構、優化資源配置、降低公司經營風險和提高公司發展質量,公司決定對相關業務進行調整,並出售參股公司中小微公司的全部股權。經公司多方詢價,最終確定交易對手方為深圳市芸通投資有限公司(以下簡稱“芸通投資”),並以交易對價人民幣1.017億元轉讓公司所持中小微公司約14.19%的股權以及尚未經工商登記的2,200萬元增資權益及其全部附屬、衍生權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.